i-Base home
Search Menu
  • Home
  • HTB
  • 2019
  • August

August 2019

Contents

Editorial

  • HTB 23 August 2019 online: second reports from IAS 2019

Special reports

  • Fit for purpose: antiretroviral treatment optimisation July 2019

Conference reports

  • 10th IAS Conference on HIV Science (IAS 2019) in Mexico City
  • Four days on, three days off is NOT as effective as daily ART: French study results need to be interpreted with caution
  • Switching to bictegravir/F/TAF in virally suppressed participants – including analyses by baseline drug resistance
  • Dolutegravir-based first-line non-inferior to efavirenz-based ART but associated with substantial weight gain: results from the ADVANCE study
  • Dolutegravir for younger children: results from the ODYSSEY trial
  • PK advantages of TAF/FTC over TDF/FTC for HIV PrEP might compensate for low adherence: sub-analysis of DISCOVER study

Antiretrovirals

  • Cabotegravir/rilpivirine long-acting injectable HIV drugs submitted to EMA

PDFs

  • 23 August 2019 vol 20 no 10
  • HTB RSS

Early access

  • Latest news on the US crisis and its impact on global health 30 May 2025
  • IAS-USA update in drug resistance mutations (2025) 29 May 2025
  • Vaccination is effective in limiting mpox progression – but lower efficacy in people living with HIV 27 May 2025
  • US update guidelines for statin use in people living with HIV 26 May 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Latest news on the US crisis and its impact on global health 30 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook